Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Nova Eye Medical Ltd
EYECurrent price
0.15 AUD
-0.01 AUD (-6.25%)
Last closed
0.16 AUD
Company
www.nova-eye.com
ISIN
AU0000094252
Sector
Healthcare
Industry
Medical Devices
Exchange
Australian Securities Exchange
Capitalization
37 109 674 AUD
Yield for 12 month
+11.11 %
1Y
3Y
5Y
10Y
15Y
EYE
Nova Eye Medical Limited designs, develops, manufactures, markets, and sells surgical devices for the treatment of glaucoma in Australia, the United States, Europe, the Asia Pacific, and internationally. The company offers iTrack, a glaucoma surgical device to reduce intraocular pressure in adult patients with open-angle glaucoma; iTrack Advance, a canaloplasty microcatheter which offers malleability and manoeuvrability than common nylon alternatives; Molteno3, a glaucoma drainage device to treat patients with severe or complex glaucoma; and 2RT, a proprietary laser technology to treat patients in early/intermediate age-related macular degeneration. The company was formerly known as Ellex Medical Lasers Limited and changed its name to Nova Eye Medical Limited in July 2020. Nova Eye Medical Limited was incorporated in 1970 and is headquartered in Kent Town, Australia. Address: 107 Rundle Street, Kent Town, SA, Australia, 5067
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
1.08 AUDP/E ratio
–Dividend Yield
–Current Year
+23 617 706 AUD
Last Year
+17 238 646 AUD
Current Quarter
+13 351 472 AUD
Last Quarter
+10 266 234 AUD
Current Year
+20 446 403 AUD
Last Year
+852 566 AUD
Current Quarter
+11 401 302 AUD
Last Quarter
+1 338 590 AUD
Key Figures EYE
1 year
3 years
5 years
10 years
EBITDA
-6 054 031 AUD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-18.61 %
PEG Ratio
–
Return On Equity TTM
-39.49 %
Wall Street Target Price
1.08 AUD
Revenue TTM
23 617 706 AUD
Book Value
0.094 AUD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
52.7 %
Dividend Yield
–
Gross Profit TTM
14 574 630 AUD
Earnings per share
-0.041 AUD
Diluted Eps TTM
-0.041 AUD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-37.69 %
Dividend Analytics EYE
Dividend growth over 5 years
–Continuous growth
1 yearPayout Ratio 5 years average
-403 %Dividend History EYE
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
21.07.2020
Forward Annual Dividend Yield
–
Last Split Factor
1:5
Payout Ratio
–
Last Split Date
10.07.2001
Dividend Date
–
Stock Valuation EYE
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
1.3038
Price Sales TTM
1.5713
Enterprise Value EBITDA
-3.9647
Price Book MRQ
1.5571
Financials EYE
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators EYE
For 52 weeks
0.12 AUD
0.33 AUD
50 Day MA
0.18 AUD
Shares Short Prior Month
–
200 Day MA
0.23 AUD
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart